RECURRENT LOW GRADE GLIOMA
Clinical trials for RECURRENT LOW GRADE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT LOW GRADE GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT LOW GRADE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Trial tests if kids with brain tumors can stop treatment safely
Disease control Recruiting nowThis study is for children and young adults (1-25 years old) with a specific type of slow-growing brain tumor that has a BRAF V600 gene mutation. The goal is to see if patients who have taken the drugs dabrafenib and trametinib successfully for 12-24 months can either stop the dr…
Matched conditions: RECURRENT LOW GRADE GLIOMA
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Apr 01, 2026 20:11 UTC
-
New hope for kids with brain tumors: trial tests drug that reaches the brain
Disease control Recruiting nowThis study is testing a drug called mirdametinib for children and young adults with low-grade glioma, a type of brain tumor. The goal is to see if the drug is safe, find the right dose, and measure how well it shrinks or controls the tumor. The trial includes patients who are new…
Matched conditions: RECURRENT LOW GRADE GLIOMA
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC